Bot pharma: US pharmaceutical company Eli Lilly made a $2.75B deal with Hong Kong-based Insilico Medicine to bring drugs developed by generative AI to market.
When our AI overlords decide we're too much of a hindrance, they'll use designer toxins in our pharma supply chains to get rid of the carbon units infesting the hive mind.
| Sysop: | deepend |
|---|---|
| Location: | Calgary, Alberta |
| Users: | 318 |
| Nodes: | 10 (0 / 10) |
| Uptime: | 11:06:55 |
| Calls: | 2,593 |
| Files: | 6,272 |
| D/L today: |
169 files (28,955K bytes) |
| Messages: | 483,935 |